New treatment for cystic fibrosis.
Kuhn
R J
RJ
University of Kentucky College of Pharmacy, Lexington.
D000328:Adult; D002986:Clinical Trials as Topic; D003376:Counseling; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000503:physiopathology; D003850:Deoxyribonuclease I / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004356:Drug Storage; D006801:Humans; D009330:Nebulizers and Vaporizers; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use
D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I